Mistral Pharma Inc.
TSX VENTURE : MIP

Mistral Pharma Inc.

September 06, 2005 10:31 ET

Mistral Pharma Announces its Eligibility to the List Drawn Up by the Autorite des Marches Financiers for the SME Growth Stock Plan

MONTREAL, QUEBEC--(CCNMatthews - Sept. 6, 2005) - Mistral Pharma Inc. ("Mistral") (TSX VENTURE:MIP) announces today it has obtained an advance income tax ruling from the ministere du Revenu du Quebec confirming that the common shares of Mistral could be included on the list drawn up by the Autorite des marches financiers ("AMF") and be valid shares for the SME Growth Stock Plan, in accordance with the measures contained in the 2005-2006 Quebec budget tabled on April 21, 2005. In this regard, an application for registration has already been filed before the AMF and the common shares of Mistral will be included on the AMF list shortly.

As a result, when the common shares of Mistral will be included on the AMF list, the common shares of Mistral purchased on the secondary market to replace a qualifying share or security disposed of by an individual (other than a trust) will qualify as valid shares for a "covering" operation in accordance with the SME Growth Stock Plan.

About Mistral Pharma Inc.

Mistral Pharma is an emerging oral drug delivery company which develops generic and branded controlled-delivery products using its PROCISE™, SAVIT™ and CHRONOP™ geometry surface area technologies. These technologies offer many competitive advantages including flexible and fast development, competitive cost of goods and the use of "generally recognized as safe" excipients. Additional information about Mistral Pharma can be obtained on Mistral Pharma's website at www.mistralpharma.com.

The TSX Venture Exchange does not accept responsibility for the adequacy or accuracy of this press release.

Contact Information

  • Mistral Pharma Inc.
    Bertrand F. Bolduc, B.Pharm., MBA
    President and Chief Executive Officer
    (514) 920-0909 ext. 24
    bbolduc@mistralpharma.com
    or
    Mistral Pharma Inc.
    Alain Provencher, CA
    Vice President and Chief Financial Officer
    (514) 920-0909 ext. 22
    aprovencher@mistralpharma.com